The Medicines and Healthcare products Regulatory Agency (MHRA) is a UK government agency responsible for ensuring that medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy.
Based on publicly published press releases (last 12 months)
782 articles
Showing 1-30
Thursday, 08 January 2026
Updated product information and packaging will help patients better understand the risks of dependency, addiction, and withdrawal with these medicines...
Thursday, 08 January 2026
As medicines and medical technologies become more complex, there are exciting opportunities to further strengthen our safety monitoring systems....
Wednesday, 07 January 2026
As with any medicine, the MHRA will keep the safety and effectiveness of Nirogacestat hydrobromide under close review. ...
Monday, 05 January 2026
In this new role, Professor George will lead the Agency’s science strategy and will oversee the MHRA’s scientific, research and innovation activities....
Friday, 02 January 2026
As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review....
Monday, 29 December 2025
As many people consider lifestyle changes at the start of the year, the Medicines and Healthcare products Regulatory Agency (MHRA) is urging the publi...
Wednesday, 24 December 2025
As colder weather arrives, the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Fire Chiefs Council (NFCC) are urging the p...
Tuesday, 23 December 2025
Understanding gut microbiome interactions with medicines could help explain differences in how people respond to treatment and build on existing medic...
Monday, 22 December 2025
As the cold weather sets in and coughs and colds become more common, the MHRA is reminding people that small, everyday choices can make a big differen...
Friday, 19 December 2025
As with any medicine, the MHRA will keep the safety and effectiveness of lenacapavir under close review....
Thursday, 18 December 2025
National Commission is seeking evidence to shape regulation of AI in healthcare and support the UK’s ambition for a world-leading, AI-enabled NHS ...
Wednesday, 17 December 2025
Updated MHRA guidance will help health institutions, such as NHS Trusts and Boards, safely design and make general medical devices for patients....
Tuesday, 16 December 2025
Exploring the MHRA's transformational impact on access, experience, and outcomes....
Monday, 15 December 2025
As with any medicine, the MHRA will keep the safety and effectiveness of depemokimab under close review....
Monday, 15 December 2025
As with any medicine, the MHRA will keep the safety and effectiveness of fluticasone propionate under close review.?...
Monday, 15 December 2025
This holiday season, the MHRA is reminding people that some common festive foods can interact with medicines, altering how well they work or increasin...
Monday, 15 December 2025
Professor Benger’s leadership comes at a pivotal time as the MHRA and NICE deepen collaboration...
Friday, 12 December 2025
Patients in the UK and Singapore could gain faster access to cutting-edge healthcare innovations under a new partnership bringing two globally respect...
Thursday, 11 December 2025
Professor Anthony Harnden has congratulated the trio of Agency board members on the extension of their appointments....
Thursday, 11 December 2025
As with any medicine, the MHRA will keep the safety and effectiveness of mirdametinib under close review.?...
Tuesday, 09 December 2025
The MHRA and Northern Ireland partners are working together to support innovation, enhance patient safety and ensure people in Northern Ireland benefi...
Monday, 08 December 2025
This holiday season, the MHRA is highlighting one of the most overlooked winter health risks: combining medicines with alcohol....
Saturday, 06 December 2025
All babies in the UK get the hepatitis B vaccine. It has a well-established safety record and ensures long-term protection against the virus. ...
Wednesday, 03 December 2025
A story of hope, medical innovation, and the impact of effective regulation on access to treatment....
Tuesday, 02 December 2025
As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used...
Monday, 01 December 2025
An Expert Working Group has completed a review into how the potential risks associated with antidepressant medicines are communicated to patients ...
Monday, 01 December 2025
The MHRA has five top tips to help you stay well through the festive season and beyond...
Thursday, 27 November 2025
Study provides crucial insights for targeting rapid response strategies and improving polio surveillance worldwide ...
Thursday, 27 November 2025
Additional funding will allow the MHRA and NICE to continue developing clear, proportionate guidance for digital mental health technologies, supportin...
Wednesday, 26 November 2025
The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive ...
Ministry of Defence UK to develop new deep strike ballistic missile for Ukraine
Department for Transport How well is your council fixing your roads?
Civil Nuclear Constabulary Scottish teams' dedication praised during severe winter weather
Prime Minister's Office, 10 Downing Street Appointment: 9 January 2026
Open Innovation Team Open Innovation Team PhD Placement Scheme 2026-27
Ministry of Justice NHS and probation join forces to break cycle of reoffending
The Charity Commission Regulator investigates charity over concerns about asset sale